A file picture of the headquarters of the WHO in Geneva, Switzerland (Reuters)
Geneva:
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the UN agency's chief scientist Soumya Swaminathan said on Thursday.
Her comments come after the WHO on Wednesday stopped testing of the malaria drug hydroxychloroquine in the trial of treatments for COVID-19 patients, after studies indicated it showed no benefit in those who have the disease. She said more study was needed to see whether hydroxchloroquine could prevent infection.
-
-
World-Class Chefs, Food And Music: The Fun Side Of NDTV World Summit 2026 -
AI, Consciousness And Dharma: Why Ancient Indian Wisdom Matters Now -
NDTV World Summit: What To Expect From PM Modi's Keynote Address -
NDTV World Summit 2026: What To Watch Out For | PM Modi, Jaishankar, AI And Global Power Shifts -
A World Between Orders: What To Expect At NDTV World Summit 2026 -
Who Is Rajiv Mehta? Lilavati Hospital Trustee To Speak At NDTV World Summit 2026 -
Alain Ebobisse, Africa50 CEO, To Attend NDTV World Summit 2026. All About Him -
Kriti Sanon At NDTV World Summit: A Look At Her Career And Business Ventures -
Ex-CIA Director To Decode 'War In Times Of AI' At NDTV World Summit -
Who Is Vikram Rai, CEO, South Asia GE Aerospace, Set To Attend The NDTV World Summit 2026
How may i help you today
Show full article
